Tuesday, 20 May 2008

AstraZeneca jumps on hope for Quetiapine patent win


A U.S. court hearing over patents on AstraZeneca's blockbuster schizophrenia drug Seroquel (Quetiapine) has been brought forward to Tuesday from June 4, boosting hopes the Anglo-Swedish group may prevail in the case. (Link)

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker